NCT06386653 Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1 Status COMPLETED Phase PHASE1
NCT06385912 Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer Status COMPLETED Phase N/A
NCT06383507 A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06380660 Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06379191 The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program Status COMPLETED Phase NA
NCT06377267 Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) Status RECRUITING Phase PHASE2
NCT06376253 A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Status TERMINATED Phase PHASE1
NCT06366490 Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer Status RECRUITING Phase PHASE1
NCT06342986 Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06342934 Radiomics and Machine Learning in the Diagnosis of Ovarian Masses Status COMPLETED Phase N/A
NCT06337084 Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06329323 SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours Status NOT_YET_RECRUITING Phase N/A
NCT06321484 Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer Status RECRUITING Phase PHASE1
NCT06320418 The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06317610 Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids Status RECRUITING Phase N/A
NCT06307249 Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA Status RECRUITING Phase PHASE1